Exploring preferences of at-risk individuals for preventive treatments for rheumatoid arthritis (2022) Simons G, Bywall KS, Englbrecht M, Johansson EC, Disantostefano RL, Radawski C, Veldwijk J, et al. Journal article Myositis-specific and myositis-associated autoantibodies predict trajectories of damage over time in idiopathic inflammatory myopathies (2021) Espinosa-Ortega F, Holmqvist M, Lodin K, Dastmalchi M, Danieli MG, Venkovsky J, Knitza J, et al. Conference contribution Heterogenous bone response to biologic DMARD therapies in rheumatoid arthritis patients and their relationship to functional indices (2021) Brunet SC, Tse JJ, Kuczynski MT, Engelke K, Boyd SK, Barnabe C, Manske SL Journal article Is synovitis detected on non-contrast-enhanced magnetic resonance imaging associated with serum biomarkers and clinical signs of effusion? Data from the Osteoarthritis Initiative (2018) Deveza LA, Kraus VB, Collins JE, Guermazi A, Roemer F, Nevitt MC, Hunter DJ Journal article Impact of secukinumab treatment on psoriatic arthritis patients with or without enthesitis at baseline: pooled data from two phase 3 studies (FUTURE 2 and FUTURE 3) (2018) Wallman JK, Schett G, Mcinnes IB, Quebe-Fehling E, Rasouliyan L, Pricop L, Gaillez C, Fasth AE Conference contribution There is a need for new systemic sclerosis subset criteria. A content analytic approach (2017) Johnson S, Soowamber M, Fransen J, Khanna D, Van Den Hoogen F, Baron M, Matucci-Cerinic M, et al. Journal article Decreased IL-10(+) regulatory B cells (Bregs) in lupus nephritis patients (2016) Heinemann K, Wilde B, Hoerning A, Tebbe B, Kribben A, Witzke O, Dolff S Journal article